by Brandon Tudor | Apr 6, 2026 | Blog
There’s an important article titled “Par for the course? Comparative effectiveness of PPAR agonists in PBC” from April 2026 in Hepatology by Robert M. Wilechansky, and it’s summarized below– 🧠Summary 1) Context: why this matters Primary...
by Brandon Tudor | Apr 3, 2026 | Blog
Here’s a summary on this April 2, 2026 article from USC Keck – “Occasional Heavy Drinking May Triple the Risk of Liver Damage.” 🧠Key takeaway Even occasional heavy drinking (binge episodes) can significantly increase liver damage...
by Pete Celano | Apr 1, 2026 | Blog
This article is worth reading, from JAMA Internal Medicine dated March23, 2026: “Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies”. 🎯 Objective The study evaluated whether screening, treating, and supporting...
by Pete Celano | Mar 30, 2026 | Blog
US Healthcare is changing. Fast. There’s supernormal change– perhaps transformation, even, as four factors collide. From the March 10, 2026 in The Economist: A new wave of disrupters takes on American health care Patients are unhappy. Can AI help? Summary:...
by David Sires | Mar 28, 2026 | Blog
by Brandon Tudor | Mar 27, 2026 | Blog
The March 2026 journal article titled “Increasing Transplant Access for Low MELD Patients in the United States: Do We Still Need to Increase Adult Living Donor Liver Transplantation?” is thought provoking. Study Overview This study examines whether living...
